(Q40531153)

21 September 2017

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome (English)

1 reference

21 September 2017

Michael Callister

1

1 reference

21 September 2017

Lois M Ramondetta

2

1 reference

21 September 2017

Anuja Jhingran

3

1 reference

21 September 2017

Thomas W Burke

4

1 reference

21 September 2017

Patricia J Eifel

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

International Journal of Radiation Oncology Biology Physics

21 September 2017

1 reference

21 September 2017

58

1 reference

21 September 2017

3

1 reference

21 September 2017

786-796

1 reference

Uterine carcinosarcomas: incidence and trends in management and survival

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Clinicopathologic analysis of uterine malignant mixed müllerian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Malignant mixed müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Uterine sarcoma: an analysis of 74 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Results of primary and adjuvant radiotherapy in the treatment of mixed Müllerian tumors of the corpus uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Patterns of recurrence in malignant mixed müllerian tumor of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Management of malignant, mixed mesodermal tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Adjuvant therapy in mixed mullerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

The impact of adjuvant radiotherapy on carcinosarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Peritoneal cytology in malignant mixed müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

An excess of uterine sarcomas after pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901561-X

7 January 2021

10.1016/S0360-3016(03)01561-X

Identifiers

DOI

1 reference

21 September 2017

1 reference